Patent · US Active

Modulation of transgene expression in plants

US11473095B2 · kind B2 · utility

2Cited by
3References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 2020
Grant dateOct 18, 2022
Priority date
Expiry dateApr 23, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A40/146
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This disclosure concerns the use of endogenous plant RNAi machinery to preferentially or specifically reduce transgene expression. In some embodiments, the disclosure concerns specific reduction of transgene expression in seed tissues of a dicot plant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.